ACCEL-ENTECAVIR
Identification of Accel-Entecavir
| No description |
Google image searchProduct monograph
Active ingredient
entecavir (entecavir monohydrate), 0.5 MG
DIN: 02479907
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: ACCEL PHARMA INC
Date: 11-MAR-2020
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AF — Nucleoside and nucleotide reverse transcriptase inhibitors (ATC, ATC/DDD)
- J05AF10 — ENTECAVIR (ATC/DDD)
Reference brand drug: Baraclude
